Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
CNMD 
CONMED Corporation (CNMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: CNMD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -35.23% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.87B USD | Price to earnings Ratio 14.22 | 1Y Target Price 77.29 |
Price to earnings Ratio 14.22 | 1Y Target Price 77.29 | ||
Volume (30-day avg) 481650 | Beta 1.54 | 52 Weeks Range 55.03 - 79.71 | Updated Date 04/2/2025 |
52 Weeks Range 55.03 - 79.71 | Updated Date 04/2/2025 | ||
Dividends yield (FY) 1.35% | Basic EPS (TTM) 4.25 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 10.13% | Operating Margin (TTM) 15.54% |
Management Effectiveness
Return on Assets (TTM) 4.32% | Return on Equity (TTM) 14.74% |
Valuation
Trailing PE 14.22 | Forward PE 27.03 | Enterprise Value 2717306799 | Price to Sales(TTM) 1.43 |
Enterprise Value 2717306799 | Price to Sales(TTM) 1.43 | ||
Enterprise Value to Revenue 2.08 | Enterprise Value to EBITDA 9.98 | Shares Outstanding 30908800 | Shares Floating 30646419 |
Shares Outstanding 30908800 | Shares Floating 30646419 | ||
Percent Insiders 0.5 | Percent Institutions 118.4 |
Analyst Ratings
Rating 3.71 | Target Price 81.14 | Buy 3 | Strong Buy 1 |
Buy 3 | Strong Buy 1 | ||
Hold 3 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
CONMED Corporation
Company Overview
History and Background
CONMED Corporation was founded in 1970. Initially focused on electrosurgical products, it has grown through organic expansion and acquisitions to offer a broad range of medical devices and equipment.
Core Business Areas
- Orthopedic Surgery: Offers a wide range of products for orthopedic procedures, including arthroscopy, sports medicine, and large bone reconstruction.
- General Surgery: Provides devices for electrosurgery, surgical visualization, and other general surgical needs.
- Advanced Surgical: This includes products like tissue sealers, smoke evacuators, and energy-based instruments.
Leadership and Structure
CONMED is led by a CEO and executive team. The organizational structure is divided into business units corresponding to its core business areas.
Top Products and Market Share
Key Offerings
- Arthroscopic Solutions: CONMED offers a comprehensive suite of arthroscopic products, including visualization systems, fluid management, and resection devices. Competitors: Stryker, Smith & Nephew. Market share data unavailable to provide exact percentage.
- Electrosurgical Generators: These generators are used in a variety of surgical procedures. Competitors: Medtronic, Ethicon. Market share data unavailable to provide exact percentage.
- Laparoscopic Instrumentation: CONMED offers a variety of laparoscopic instruments and access systems. Competitors: Medtronic, Johnson & Johnson. Market share data unavailable to provide exact percentage.
Market Dynamics
Industry Overview
The medical device industry is characterized by technological innovation, stringent regulatory requirements, and increasing demand driven by an aging population and rising healthcare expenditures.
Positioning
CONMED holds a strong position in specific segments of the medical device market, particularly in orthopedics and general surgery. Its competitive advantages include its established brand, broad product portfolio, and strong distribution network.
Total Addressable Market (TAM)
The global medical device market is estimated to be several hundred billion USD. CONMED is positioned to capture a portion of this TAM, focusing on specific surgical segments.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Established brand reputation
- Strong distribution network
- Focus on innovation
Weaknesses
- Smaller size compared to major competitors
- Reliance on specific product segments
- Potential pricing pressure
Opportunities
- Expanding into emerging markets
- Developing new innovative products
- Acquiring complementary businesses
- Increasing adoption of minimally invasive surgery
Threats
- Intense competition
- Technological advancements from competitors
- Regulatory changes
- Economic downturns impacting healthcare spending
Competitors and Market Share
Key Competitors
- Stryker (SYK)
- Smith & Nephew (SNN)
- Medtronic (MDT)
- Johnson & Johnson (JNJ)
Competitive Landscape
CONMED faces intense competition from larger players in the medical device industry. While it has a strong position in specific niches, it needs to continue innovating and expanding its product portfolio to maintain its competitive edge.
Major Acquisitions
Biorez, Inc.
- Year: 2022
- Acquisition Price (USD millions): 85
- Strategic Rationale: Expands sports medicine portfolio with BioRez's BioBrace Implant, a novel bioinductive scaffold.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data unavailable to populate.
Future Projections: Future growth projection data unavailable to populate.
Recent Initiatives: CONMED has focused on acquisitions and product development to drive growth. Recent initiatives include launching new products and expanding its presence in key markets.
Summary
CONMED is a medical device company with a strong position in orthopedics and general surgery. While it faces competition from larger companies, its focus on innovation and acquisitions has driven growth. Key areas to watch are regulatory changes and the impact of economic downturns. The company should continue to strategically leverage its core business areas and look to capitalize on the ever expanding aging population.
Similar Companies
BSX
Boston Scientific Corp
BSX
Boston Scientific Corp
JNJ
Johnson & Johnson
JNJ
Johnson & Johnson
MDT
Medtronic PLC
MDT
Medtronic PLC
SNN
Smith & Nephew SNATS Inc
SNN
Smith & Nephew SNATS Inc
SYK
Stryker Corporation
SYK
Stryker Corporation
Sources and Disclaimers
Data Sources:
- Company filings, industry reports, analyst estimates.
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share percentages are estimates and may vary depending on the source. Financial data is unavailable due to limitations.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CONMED Corporation
Exchange NYSE | Headquaters Largo, FL, United States | ||
IPO Launch date 1987-07-23 | President, CEO & Director Mr. Patrick J. Beyer | ||
Sector Healthcare | Industry Medical Devices | Full time employees 3900 | Website https://www.conmed.com |
Full time employees 3900 | Website https://www.conmed.com | ||
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.